Dan Gladney

Bio

Dan brings more than 25 years of entrepreneurship, strategy, business development and CEO experience to NEP. Dan initially joined NEP in 2007 as a healthcare operating partner but transitioned to a senior advisor role in January 2011. As a senior advisor, he helps evaluate and execute new investment opportunities and add-on acquisitions within the healthcare products, services, and distribution industry sectors. In addition to his role at NEP, Dan serves as CEO at Lanx, a medical device company focused on developing and commercializing innovative devices for spinal surgery. Dan is also Founder and Chairman of DGIMED ORTHO, a company focused on developing Orthopedic Trauma Implant products, and he co-founded Heartleaflet Technologies, a high-tech cardiovascular device start-up developing a percutaneous aortic heart valve system, which was acquired by Bracco s.P.a. Prior to these roles, Dan served as Chairman, CEO, and President of Compex Technologies, a public company in the orthopedic and health and wellness electro therapy industry which was acquired by Encore Medical Corporation. While at Compex, he repositioned and restructured the company, completed several acquisitions, and drove top line growth from an average of 5% per year to 15% in a declining market. Prior to Compex, Dan served as President and CEO of Acist Medical Systems, a cardiovascular device start-up that was also acquired by Bracco s.P.a. He was responsible for growing the company through raising capital from investors, building a solid management team, and preparing the company for an IPO before its acquisition. Dan has also worked with Baxter and The Kendall Company, and was named as one of the “Top 40 CEOs to Watch in 2004” by The Business Journal. Shock Doctor BBA, Eastern Michigan University. MBA coursework, Pepperdine University.